COMMUNIQUÉS West-GlobeNewswire
-
Acorn Health Expands Autism Diagnostic Evaluations in Florida
29/06/2026 -
BrewDog and Tilray Beer Add Canada to The World's Biggest Bar Tab as Canada Advances to the Next Round
29/06/2026 -
EmblemHealth Sees 50% Increase in Member Adoption and Engagement Following Debut of Redesigned Mobile App
29/06/2026 -
Résultats AGE - 29 juin 2026
29/06/2026 -
EssilorLuxottica: Disclosure of transactions in own shares
29/06/2026 -
EssilorLuxottica: Déclaration de transactions sur actions propres
29/06/2026 -
Father and son climb Kilimanjaro for Human Appeal’s humanitarian work
29/06/2026 -
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 mai 2026
29/06/2026 -
TerrAscend Files Preliminary Proxy Statement for Special Meeting of Shareholders in Preparation for Uplisting to US Exchange
29/06/2026 -
Zealand Pharma - Transactions related to share buy-back program (week 26, 2026)
29/06/2026 -
SoldierStrong Donates Life-Changing ExoSym® Device to Marine Corps Veteran and Former Police Officer
29/06/2026 -
Acentra Health Executives Meghan Harris and Verlon Johnson Recognized on Becker’s Healthcare’s 2026 Women in Health IT to Know List
29/06/2026 -
New Video Series “Ahead of Alzheimer’s” Launches Focused on a Renewed Look at Early Alzheimer’s Detection and Preventive Brain Health Care
29/06/2026 -
Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government
29/06/2026 -
SPR Wins Fifth Consecutive Northeast Ohio Top Workplaces Award
29/06/2026 -
Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression
29/06/2026 -
Tria Federal Earns Three Positions on NASA SEWP VI Government-Wide IT Contract
29/06/2026 -
Cannabix Technologies Announces First BreathLogix Alcohol Device Deployment to West Africa for Mining Sector
29/06/2026 -
Artelo Biosciences Presents Clinical and Biomarker Data Supportive of the Development of ART26.12 and Follow-On FABP5 Inhibitors at ICRS 2026
29/06/2026
Pages